HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer].

Abstract
An 81-year-old man, who had no history of taking statins, developed progressive muscle weakness of the limbs and dysphagia. Laboratory tests showed a high level of CK and positivity for serum 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) antibodies. Tests for other autoantibodies to ARS and SRP were negative. A pathological analysis of the left biceps muscle revealed numerous necrotic and regenerated fibers with macrophage infiltration and deposition of C5b-9 complement in and around the myofibers. Chest CT showed a nodular shadow, which was suspected to be lung cancer, in the upper left lobe. A pathological analysis of a transbronchial lung biopsy specimen revealed lung adenocarcinoma with high level of HMGCR. He was diagnosed with HMGCR necrotizing myopathy associated with lung cancer, and both his muscle strength and dysphagia improved after three treatments with intravenous immunoglobulin (IVIg). He did not undergo surgery or radiation therapy because of interstitial pneumonia. This case suggests that a paraneoplastic mechanism caused the production of HMGCR antibodies, leading to myositis in this patient. Treatment with IVIg can be effective for patients with HMGCR antibody-positive paraneoplastic necrotizing myopathy that is refractory to corticosteroid therapy.
AuthorsNanami Yamanaka, Ryota Sato, Mariko Oishi, Fumitaka Shimizu, Michiaki Koga, Yoshinobu Hoshii, Takashi Kanda
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 61 Issue 7 Pg. 456-460 (Jul 30 2021) ISSN: 1882-0654 [Electronic] Japan
PMID34148931 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Immunoglobulins, Intravenous
  • Hydroxymethylglutaryl CoA Reductases
Topics
  • Adenocarcinoma of Lung (complications, diagnosis)
  • Aged, 80 and over
  • Autoantibodies
  • Deglutition Disorders
  • Humans
  • Hydroxymethylglutaryl CoA Reductases (immunology)
  • Immunoglobulins, Intravenous (therapeutic use)
  • Lung Neoplasms (complications, diagnosis)
  • Muscular Diseases (diagnosis, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: